Integra LifeSciences

Yahoo Finance • 25 days ago

Global Intracranial Pressure Monitoring Devices Market Size/Share Worth USD 3.71 Billion by 2035 at a 7.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Intracranial Pressure Monitoring Devices Market size & share revenue was valued at ap... Full story

Yahoo Finance • 26 days ago

Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility

[Black Bull and Bear] peterschreiber.media/iStock via Getty Images Small-cap outperformance has narrowed over the last couple of weeks as investor caution increased, with volatility and geopolitical risk weighing on risk appetite and narr... Full story

Yahoo Finance • last month

Integra LifeSciences Holdings is Now Oversold (IART)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • last month

Stocks making big moves this week: Flywire, First Advantage, Integra LifeSciences, Huron, and Montrose

Check out the companies making headlines this week: Flywire (NASDAQ:FLYW): Global payments company Flywire (NASDAQ:FLYW) rose by 10.1% on Wednesday after it reported fourth-quarter 2025 results that beat Wall Street's expectations for bot... Full story

Yahoo Finance • last month

Integra LifeSciences (IART) Earnings Transcript

Image source: The Motley Fool. Date Feb. 26, 2026 at 8:30 a.m. ET Call participants Chief Executive Officer — Mojdeh PoulChief Financial Officer — Lea KnightChief Technology Officer — Teshtar Elavia Takeaways Revenue -- $435 million... Full story

Yahoo Finance • 4 months ago

Organogenesis drops as Medicare to pull skin substitute LCDs (update)

[CMS] gustavofrazao Organogenesis (ORGO [https://seekingalpha.com/symbol/ORGO]) and MiMedx (MDXG [https://seekingalpha.com/symbol/MDXG]) traded lower on Friday after the Centers for Medicare & Medicaid Services (CMS) announced the withdra... Full story

Yahoo Finance • 4 months ago

Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference

PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial office... Full story

Yahoo Finance • 5 months ago

Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access

PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare & Medicaid Services (CMS) on its Calendar Year 20... Full story

Yahoo Finance • 5 months ago

Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fur... Full story

Yahoo Finance • 5 months ago

Integra LifeSciences Reports Third Quarter 2025 Financial Results

PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2025.... Full story

Yahoo Finance • 6 months ago

Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 6 months ago

Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting

PRINCETON, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, is pleased to announce its exhibition at the CNS Annual Meeting, from October 11 th... Full story

Yahoo Finance • 7 months ago

Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer

PRINCETON, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment of Dr. Raymond Turner as its new corporate vice president and chief medical officer. Dr. Turner... Full story

Yahoo Finance • 7 months ago

Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences

PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial office... Full story

Yahoo Finance • 8 months ago

JMP reiterates Market Outperform rating on Integra LifeSciences stock

Investing.com - JMP Securities has reiterated its Market Outperform rating and $25.00 price target on Integra LifeSciences (NASDAQ:IART) following the company’s second-quarter 2025 financial results. The medical device manufacturer, curren... Full story

Yahoo Finance • 8 months ago

Integra LifeSciences Holding (NASDAQ:IART) Reports Q2 2025 Earnings Beat Amid Mixed Market Reaction

Integra LifeSciences Holding (NASDAQ:IART [https://www.chartmill.com/stock/quote/IART]) reported its second-quarter 2025 financial results, delivering revenue and earnings per share (EPS) that surpassed analyst expectations. However, the m... Full story

Yahoo Finance • 8 months ago

Integra LifeSciences Q2 Results Beat Expectations

(RTTNews) - Integra LifeSciences Holdings Corporation (IART), a medical technology company, Thursday reported net loss of $484.07 million or $6.31 per share for the second quarter, significantly higher than $12.40 million or $0.16 per shar... Full story

Yahoo Finance • 8 months ago

Integra LifeSciences Reports Second Quarter 2025 Financial Results

PRINCETON, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2025. Seco... Full story

Yahoo Finance • 9 months ago

Integra recalls MicroMyst Applicators for sterilization concerns: FDA

[Medical team performing gastric bypass surgery] Portra/E+ via Getty Images The U.S. FDA said on Monday that Integra LifeSciences (NASDAQ:IART [https://seekingalpha.com/symbol/IART]) is recalling its MicroMyst Applicators. The recall is... Full story

Yahoo Finance • 9 months ago

Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025

PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2025 financial results on Thursday, July 31, 2025, prio... Full story